Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
AVIGEN INC (AVGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/16/2009 8-K Quarterly results
12/07/2009 8-K/A Financial Statements and Exhibits
Docs: "Amendment to Management Transition Plan, effective as of August 20, 2009"
08/26/2009 8-K Form 8-K - Current report
08/25/2009 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among MediciNova, Inc., Absolute Merger, Inc. and Avigen, Inc",
"Amendment to Rights Agreement, by and between Avigen, Inc. and American Stock Transfer & Trust Co. LLC",
"Amendment to Management Transition Plan, effective as of August 20, 2009",
"JOINT PRESS RELEASE OF AVIGEN AND MEDICINOVA, DATED AUGUST 21, 2009"
08/11/2009 8-K Quarterly results
Docs: "Avigen Reports Second Quarter 2009 Financial Results"
06/25/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination SAN DIEGO and ALAMEDA, Calif., June 25, 2009 -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange , and Avigen, Inc. , a biopharmaceutical company, today announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies' broad neurological clinical development programs based on ibudilast . MediciNova and Avigen currently contemplate that the terms of the merger would provide that Avigen shareholders receive consideration approximating Avigen's net cash liquidation value plus $3 million. Avigen shareholders woul..."
05/11/2009 8-K Form 8-K -- Current report
04/22/2009 8-K Form 8-K -- Current report
04/01/2009 8-K Form 8-K -- Current report
03/26/2009 8-K Form 8-K -- Current report
02/11/2009 8-K Quarterly results
Docs: "Avigen Reports 2008 Financial Results and Updates Progress on Strategic Review"
12/23/2008 8-K Form 8-K -- Current report
11/05/2008 8-K Form 8-K -- Current report
11/03/2008 8-K Termination of a Material Definitive Agreement, Cost Associated with Exit or Disposal Activities
10/28/2008 8-K Quarterly results
Docs: "Avigen Reports Third Quarter 2008 Financial Results"
07/30/2008 8-K Quarterly results
Docs: "Avigen Reports Second Quarter 2008 Financial Results"
07/23/2008 8-K Entry into a Material Definitive Agreement
04/30/2008 8-K Quarterly results
Docs: "Avigen Reports First Quarter 2008 Financial Results and Discusses AV650 Patent Strategy"
02/14/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
02/06/2008 8-K Quarterly results
Docs: "Avigen Reports 2007 Financial Results and Reviews Clinical Progress"
12/07/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/07/2007 8-K Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Termination of Sublease Agreement between Avigen, Inc. and Pepgen Corporation"
10/24/2007 8-K Quarterly results
Docs: "Conference Call Scheduled for 1:30 p.m. on Wednesday, October 24, 2007"
07/25/2007 8-K Quarterly results
Docs: "Avigen Reports Second Quarter 2007 Financial Results"
06/26/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INC"
06/06/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Letter Agreement, between Wells Fargo Bank, National Association and Avigen, Inc",
"Promissory Note, issued by Avigen, Inc. in favor of Wells Fargo Bank, National Association"
04/26/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement",
"Opinion of Cooley Godward Kronish LLP",
"Avigen Announces Pricing of Common Stock Offering"
04/24/2007 8-K Quarterly results
Docs: "Avigen Reports First Quarter 2007 Financial Results"
03/28/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
02/07/2007 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Avigen Reports 2006 Financial Results and Reviews Clinical Progress"
02/07/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
01/05/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
11/02/2006 8-K Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from Ernst & Young LLP to Securities and Exchange Commission"
10/25/2006 8-K Quarterly results
Docs: "PRESS RELEASED, DATED OCTOBER 25, 2006,"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy